Price target
137.530.000.00%
The 8 analysts offering 1 year price forecasts for LGDN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to LGDN in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
LGDN EPS for the last quarter is 1.65 EUR despite the estimation of 1.21 EUR. In the next quarter EPS is expected to reach 1.15 EUR. Track more of LIGAND PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter LIGAND PHARMACEUTICALS INC revenue is expected to reach 37.70 M EUR. Check out LIGAND PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, LGDN price target is 137.53 EUR with a max estimate of 154.56 EUR and a min estimate of 120.75 EUR. Check if this forecast comes true in a year, meanwhile watch LIGAND PHARMACEUTICALS INC stock price chart and keep track of the current situation with LGDN news and stock market news.
We've gathered opinions of 7 analysts rating LGDN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.